Chembio Diagnostics PE Ratio 2006-2019 | CEMI

Current and historical p/e ratio for Chembio Diagnostics (CEMI) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Chembio Diagnostics PE ratio as of September 20, 2019 is 0.00.
Chembio Diagnostics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-20 7.10 0.00
2019-06-30 6.09 $-0.72 0.00
2019-03-31 5.55 $-0.65 0.00
2018-12-31 5.66 $-0.54 0.00
2018-09-30 10.50 $-0.49 0.00
2018-06-30 11.10 $-0.38 0.00
2018-03-31 8.00 $-0.44 0.00
2017-12-31 8.20 $-0.52 0.00
2017-09-30 6.20 $-0.57 0.00
2017-06-30 6.05 $-0.71 0.00
2017-03-31 5.30 $-1.39 0.00
2016-12-31 6.80 $-1.29 0.00
2016-09-30 7.40 $-1.15 0.00
2016-06-30 8.19 $-1.01 0.00
2016-03-31 5.99 $-0.22 0.00
2015-12-31 5.33 $-0.26 0.00
2015-09-30 4.03 $-0.24 0.00
2015-06-30 4.91 $-0.22 0.00
2015-03-31 4.04 $-0.17 0.00
2014-12-31 3.91 $-0.12 0.00
2014-09-30 3.72 $-0.10 0.00
2014-06-30 3.43 $0.00 0.00
2014-03-31 3.45 $-0.01 0.00
2013-12-31 3.37 $0.05 67.40
2013-09-30 3.64 $0.14 26.00
2013-06-30 5.00 $0.03 166.67
2013-03-31 5.05 $0.10 50.50
2012-12-31 4.73 $0.14 33.79
2012-09-30 4.74 $0.72 6.58
2012-06-30 4.53 $0.84 5.39
2012-03-31 3.96 $0.80 4.95
2011-12-31 3.36 $0.72 4.67
2011-09-30 3.04 $0.32 9.50
2011-06-30 3.60 $0.24 15.00
2011-03-31 3.72 $0.32 11.63
2010-12-31 3.40 $0.32 10.63
2010-09-30 1.92 $0.08 24.00
2010-06-30 2.24 $0.08 28.00
2010-03-31 1.76 0 0.00
2009-12-31 2.24 $-0.08 0.00
2009-09-30 1.60 $-0.08 0.00
2009-06-30 1.20 $-0.08 0.00
2009-03-31 0.88 $-0.16 0.00
2008-12-31 0.88 $-0.16 0.00
2008-09-30 1.20 $-2.72 0.00
2008-06-30 2.00 $-3.28 0.00
2008-03-31 1.12 $-3.84 0.00
2007-12-31 2.16 $-4.48 0.00
2007-09-30 4.00 $-1.92 0.00
2007-06-30 4.08 $-1.36 0.00
2007-03-31 5.12 $-1.76 0.00
2006-12-31 6.64 $-1.04 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.125B $0.033B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.167B 20.94
Abbott Laboratories (ABT) United States $147.719B 27.77
Stryker (SYK) United States $82.752B 28.62
Boston Scientific (BSX) United States $60.302B 29.25
Baxter (BAX) United States $44.623B 27.06
EssilorLuxottica Societe Anonyme (ESLOY) France $31.677B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.159B 18.66
Lonza Group Ag (LZAGY) Switzerland $25.836B 0.00
Coloplast (CLPBY) Denmark $25.785B 41.16
Terumo (TRUMY) Japan $23.720B 27.27
Smith & Nephew SNATS (SNN) United Kingdom $20.893B 0.00
ResMed (RMD) United States $19.328B 36.86
Sunny Optical Technology (SNPTF) China $16.573B 0.00
Bio-Rad Laboratories (BIO) United States $10.288B 55.15
Insulet (PODD) United States $9.390B 556.43
Canopy Growth (CGC) Canada $8.891B 0.00
Perrigo (PRGO) Ireland $7.516B 13.85
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.032B 20.96
Haemonetics (HAE) United States $6.572B 49.59
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.122B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.982B 0.00
Neogen (NEOG) United States $3.929B 65.23
NuVasive (NUVA) United States $3.473B 27.68
ICU Medical (ICUI) United States $3.302B 21.42
Hutchison China MediTech (HCM) China $2.696B 0.00
Quidel (QDEL) United States $2.660B 26.42
Agios Pharmaceuticals (AGIO) United States $2.133B 0.00
National Vision Holdings (EYE) United States $1.958B 42.25
Cardiovascular Systems (CSII) United States $1.782B 0.00
Aphria (APHA) $1.546B 0.00
VAREX IMAGING (VREX) United States $1.100B 25.34
Lantheus Holdings (LNTH) United States $1.024B 26.92
AtriCure (ATRC) United States $0.993B 0.00
Phibro Animal Health (PAHC) United States $0.907B 14.75
Omeros (OMER) United States $0.898B 0.00
NanoString Technologies (NSTG) United States $0.863B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 19.77
PetIQ (PETQ) United States $0.768B 18.15
Cerus (CERS) United States $0.748B 0.00
LeMaitre Vascular (LMAT) United States $0.699B 41.41
MacroGenics (MGNX) United States $0.630B 0.00
Surmodics (SRDX) United States $0.628B 119.36
Quanterix (QTRX) United States $0.610B 0.00
TG Therapeutics (TGTX) United States $0.573B 0.00
OraSure Technologies (OSUR) United States $0.472B 21.83
Meridian Bioscience (VIVO) United States $0.422B 13.16
BioLife Solutions (BLFS) United States $0.394B 129.63
Utah Medical Products (UTMD) United States $0.364B 26.64
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.360B 0.00
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.324B 34.45
United Health Products (UEEC) United States $0.258B 0.00
Bovie Medical (APYX) United States $0.249B 0.00
Rockwell Medical (RMTI) United States $0.209B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Chimerix (CMRX) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 10.20
Female Health (VERU) United States $0.128B 0.00
United-Guardian (UG) United States $0.087B 20.48
Nephros (NEPH) United States $0.065B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.028B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00